Search
for
Sort by
Research 721–750 of 1000+
- Re: Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?
- Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
- Efficacy and Safety of Thermobalancing Therapy in Men with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia was Confirmed by Clinical Trial
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- Dutasteride, finasteride: no increased risk of ED
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Impact of baseline PSA level on quality of life measures of general health and sexual satisfaction/drive in men with BPH treated with finasteride or placebo
- Patients with a large prostate show a higher prevalence of androgenetic alopecia
- Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study
- Meta-Analysis of Randomized Clinical Trials of Finasteride
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- 1194: The Long Term Effects of Doxazosin, Finasteride, and the Combination on Sexual Function in Men Participating in the MTOPS Study
- Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia
- Doxazosin and finasteride alone or in combination: the PREDICT study
- “Acute Pancreatitis Following Finasteride Toxicity: A Rare Case Report"
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Efficacy and safety of long-term administration of tamsulosin hydrochloride in patients with LUTS suggestive of BPH
- Slow progress in prostate cancer
- No increased risk of CV events with dutasteride vs finasteride
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- BPH: epidemiology and comorbidities.
- Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
- BPH: costs and treatment outcomes.
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- In Vivo Time-Dependent Inhibition of Human Steroid 5a-Reductase by Finasteride
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Synthesis and 5α-reductase inhibitory activity of 8-substituted benzo[ƒ]quinolinones derived from palladium mediated coupling reactions
- Steroid 5α-reductase inhibition by polymethoxyflavones